ABT Jan 2025 160.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
At close: 09:49AM EDT
| Previous Close | 0.0900 |
| Open | 0.0600 |
| Bid | 0.0300 |
| Ask | 1.3300 |
| Strike | 160.00 |
| Expire Date | 2025-01-17 |
| Day's Range | 0.0600 - 0.0900 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 414 |
ZacksIs Trending Stock Abbott Laboratories (ABT) a Buy Now?
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
ZacksPBH vs. ABT: Which Stock Is the Better Value Option?
PBH vs. ABT: Which Stock Is the Better Value Option?
PR NewswireAbbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is designed to keep arteries open and deliver a drug (Everolimus) to support vessel healing prior to completely dissolving.
© 2024 Yahoo. All rights reserved.